Kyverna Therapeutics, Inc. (KYTX) Reports Q1 Loss of $1.03
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Join SI Premium – FREE
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q1 EPS of ($1.03).
For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- HSBC Upgrades YPF S.A. (YPF) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
